Stay updated on the most recent developments in Symeres.
While working in big pharma, Dr. Chris Teleha spent years working with CROs in the development […]
COVID-19 has changed how we interact with people and has forced us to re-evaluate how we […]
The timely availability of high-quality APIs accelerates further investigation by our clients. To meet these pressing API needs, Symeres enables a route-scouting investigation for the API of interest.
This spring, Symeres Prague was audited by the national control authority SÚKL. After this audit, our […]
Earlier this year, our client TOLREMO therapeutics nominated the clinical candidate for a chemical series that […]
A key goal of clinical trials is to evaluate whether the potential new drug reaches its […]
Paris (France) – May 25th 2021 We are pleased to let you know that Keensight Capital, […]
In this article, one of the senior scientists from our Analytical Department talks about the challenges she encounters.
Ton is a person of simple habits, long-lasting friendships, and a photographic memory for molecular structures. He believes in the power of chemistry.